50 MIL STRONG
1 year ago
DVTC: Share structure.
https://www.otcmarkets.com/stock/DVTC/security
Authorized Shares
500,000,000
05/12/2023
Outstanding Shares
11,000,995
05/12/2023
Restricted
10,978,335
05/12/2023
Unrestricted
22,660
05/12/2023
Held at DTC
13,916
05/12/2023
Authorized Shares
500,000,000
09/30/2022
Outstanding Shares
1,000,995
09/30/2022
Restricted
978,335
09/30/2022
Unrestricted
22,660
09/30/2022
Held at DTC
13,916
09/30/2022
Authorized Shares
500,000,000
07/22/2022
Outstanding Shares
1,000,995
07/22/2022
Restricted
978,335
07/22/2022
Unrestricted
22,660
07/22/2022
Held at DTC
13,916
07/22/2022
Authorized Shares
500,000,000
06/10/2022
Outstanding Shares
250,974
06/10/2022
Restricted
228,314
06/10/2022
Unrestricted
22,660
06/10/2022
Held at DTC
13,916
06/10/2022
50 MIL STRONG
2 years ago
DVTC: Share structure.
https://www.otcmarkets.com/stock/DVTC/security
Authorized Shares
500,000,000
09/30/2022
Outstanding Shares
1,000,995
09/30/2022
Restricted
978,335
09/30/2022
Unrestricted
22,660
09/30/2022
Held at DTC
13,916
09/30/2022
Authorized Shares
500,000,000
07/22/2022
Outstanding Shares
1,000,995
07/22/2022
Restricted
978,335
07/22/2022
Unrestricted
22,660
07/22/2022
Held at DTC
13,916
07/22/2022
Authorized Shares
500,000,000
06/10/2022
Outstanding Shares
250,974
06/10/2022
Restricted
228,314
06/10/2022
Unrestricted
22,660
06/10/2022
Held at DTC
13,916
06/10/2022
50 MIL STRONG
2 years ago
DVTC: Share structure. OS increased by 750,021 and were all sent to restricted!
https://www.otcmarkets.com/stock/DVTC/security
Authorized Shares
500,000,000
07/22/2022
Outstanding Shares
1,000,995
07/22/2022
Restricted
978,335
07/22/2022
Unrestricted
22,660
07/22/2022
Held at DTC
13,916
07/22/2022
Authorized Shares
500,000,000
06/10/2022
Outstanding Shares
250,974
06/10/2022
Restricted
228,314
06/10/2022
Unrestricted
22,660
06/10/2022
Held at DTC
13,916
06/10/2022
Thugmuffin
2 years ago
$DVTC Development Technologies Corp Issues Shareholder UpdatePress Release | 06/08/2022
Development Technologies Corp. (formerly Pegasus Pharmaceuticals Inc.) (the "Company") has completed a name change to Development Technologies Corp as well as a symbol change to DVTC. Additionally, a 1 for 1,000 stock split was effectuated in early May 2022.
On June 8th 2022, the Company executed a definitive agreement to purchase 25% of Castle Heights West LLC in exchange for 750,021 shares of common stock of the Company. The closing is scheduled to take place on or before June 20,2022. Samuel Eisenberg, the Companys CEO, is also the managing member of Castle Heights West, LLC. The terms of the agreement were completed at arms-length.
The Company launched a website to provide ongoing information of its new direction as a Real Estate Technology Company. www.developmenttechnologiescorp.com.
The new website is in beta form. However, it provides information of the new direction the Company has taken. Samuel Eisenberg, the current CEO, has announced the potential acquisition of certain real estate operations and assets.
Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.
AskMuncher
3 years ago
$PGUZ Pegasus Pharmaceuticals Inc. applies for Name and Symbol change, anticipates new direction
Press Release | 12/30/2021
Pegasus Pharmaceuticals Inc. (OTC Pink: PGUZ) has announced today that it has started the process for a name change to Development Technologies Corp., and a symbol change to DVTC.
The Company has also launched a new website to provide ongoing information of its new direction as a Real Estate Technology Company. See www.developmenttechnologiescorp.com.
The new website is in beta form. However, it provides information of the new direction the Company has taken. Samuel Eisenberg, the current CEO, has announced the potential acquisition of certain real estate operations and assets.
The closings are expected to take place in all stock deals. The deals are expected to close in three (3) phases during the next 90 days or Q1 of 2022.
Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact:
Samuel Eisenberg
917.930.2025